bw a522 has been researched along with adenosine in 5 studies
| Studies (bw a522) | Trials (bw a522) | Recent Studies (post-2010) (bw a522) | Studies (adenosine) | Trials (adenosine) | Recent Studies (post-2010) (adenosine) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 32,536 | 1,075 | 8,930 |
| Protein | Taxonomy | bw a522 (IC50) | adenosine (IC50) |
|---|---|---|---|
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 0.3851 | |
| Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | 5.5 | |
| Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | 5.5 | |
| Adenosine receptor A3 | Homo sapiens (human) | 0.0011 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.0023 | |
| Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 63 | |
| Solute carrier family 28 member 3 | Homo sapiens (human) | 3.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fozard, JR; Hannon, JP | 1 |
| Bai, TR; Jacobson, MA; Knight, DA; Salvatore, CA; Walker, BA; Weir, T; Zhou, D | 1 |
| Jones, CA; Reeves, JJ; Sheehan, MJ; Vardey, CJ; Whelan, CJ | 1 |
| Auchampach, JA; Caughey, GH; Jin, X; Linden, J; Wan, TC | 1 |
| Bril, A; Broadley, KJ; Gardner, NM; Khandoudi, N; Maddock, HL | 1 |
5 other study(ies) available for bw a522 and adenosine
| Article | Year |
|---|---|
BW-A522 blocks adenosine A3 receptor-mediated hypotensive responses in the rat.
Topics: Adenosine; Animals; Blood Pressure; Depression, Chemical; Dose-Response Relationship, Drug; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Theophylline; Xanthines | 1994 |
Adenosine A3 receptor expression and function in eosinophils.
Topics: Adenosine; Animals; Bronchi; Cells, Cultured; Chemotaxis, Leukocyte; Eosinophils; Gene Expression Regulation; Humans; Hypersensitivity, Immediate; Iodobenzenes; Lung; Lung Diseases, Obstructive; Mesoderm; Molecular Sequence Data; Platelet Activating Factor; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; RNA, Messenger; Sheep; Xanthines | 1997 |
Adenosine A3 receptors promote degranulation of rat mast cells both in vitro and in vivo.
Topics: Adenosine; Administration, Cutaneous; Animals; Blood Proteins; Cell Degranulation; Cyproheptadine; Dinitrophenols; Female; Humans; In Vitro Techniques; Injections, Intravenous; Male; Mast Cells; Mice; p-Methoxy-N-methylphenethylamine; Pleura; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Receptors, Purinergic P1; Serotonin; Serotonin Antagonists; Serum Albumin; Skin; Theophylline; Triazoles; Xanthines | 1997 |
Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor.
Topics: Adenine; Adenosine; Amino Acid Sequence; Animals; Base Sequence; beta-N-Acetylhexosaminidases; Calcium; Chlorocebus aethiops; COS Cells; Dinucleoside Phosphates; DNA, Complementary; Dogs; Mast Cells; Mast-Cell Sarcoma; Molecular Sequence Data; Neoplasm Proteins; Norbornanes; Receptor, Adenosine A3; Receptors, Purinergic P1; RNA, Messenger; Sequence Alignment; Sequence Homology, Amino Acid; Xanthines | 1997 |
Protection from myocardial stunning by ischaemia and hypoxia with the adenosine A3 receptor agonist, IB-MECA.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Coronary Circulation; Endothelium, Vascular; Guinea Pigs; Heart Atria; Hypoxia; Male; Myocardial Ischemia; Myocardial Stunning; Oxygen; Papillary Muscles; Perfusion; Receptor, Adenosine A3; Reperfusion Injury; Time Factors; Xanthines | 2003 |